🇺🇸 FDA
Patent

US 7268118

Thymosin β4 compositions

granted A61KA61K38/08A61K38/1841

Quick answer

US patent 7268118 (Thymosin β4 compositions) held by United States of America as represented by the Secretary of the Air Force expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Sep 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/08, A61K38/1841, A61K38/2292, A61K45/06